Co-Diagnostics Inc New (CODX) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Co-diagnostics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.596 Hello, and thank you for standing by. My name is Tiffany, and I will be your conference 00:00:04.596 -- 00:00:10.543 operator today. At this time, I would like to welcome everyone to the Co-Diagnostics, 00:00:10.543 -- 00:00:14.948 Inc. Third Quarter 2025 Earnings Webcast. 00:00:14.948 -- 00:00:19.474 All lines have been placed on mute to prevent any background noise. 00:00:19.474 -- 00:00:24.179 After the speaker's remarks, there will be a question and answer session. 00:00:24.179 -- 00:00:29.291 If you would like to ask a question during that time, simply press star then the number 00:00:29.291 -- 00:00:31.695 one on your telephone keypad. 00:00:31.695 -- 00:00:37.023 I would now like to turn the call over to Andrew Benson, Head of Investor Relations. 00:00:37.023 -- 00:00:40.265 Andrew, please go ahead. 00:00:41.030 -- 00:00:45.437 Good afternoon, everyone. Thank you all for participating in today's conference call. 00:00:45.437 -- 00:00:50.224 On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and 00:00:50.224 -- 00:00:55.364 Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial 00:00:55.364 -- 00:00:59.650 results from the third quarter ended September 30, 2025. 00:00:59.650 -- 00:01:03.075 A copy of the press release is available on the company's website. 00:01:03.075 -- 00:01:08.403 We will begin with management's prepared remarks and then open the call to analyst Q&A. 00:01:08.403 -- 00:01:12.789 Before we begin, we would like to inform listeners that certain statements made by CoDiagnostics 00:01:12.789 -- 00:01:17.396 during this call, which are not historical facts, are forward-looking statements. 00:01:17.396 -- 00:01:22.043 In addition to diagnostic test ...